These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39303855)

  • 1. Dissociation between the anti-allodynic effects of fingolimod (FTY720) and desensitization of S1P
    Pondelick AM; Moncayo LV; Donvito G; McLane VD; Gillespie JC; Hauser KF; Spiegel S; Lichtman AH; Sim-Selley LJ; Selley DE
    Neuropharmacology; 2024 Dec; 261():110165. PubMed ID: 39303855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation.
    Sim-Selley LJ; Wilkerson JL; Burston JJ; Hauser KF; McLane V; Welch SP; Lichtman AH; Selley DE
    J Pharmacol Exp Ther; 2018 Sep; 366(3):509-518. PubMed ID: 29945931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
    Janes K; Little JW; Li C; Bryant L; Chen C; Chen Z; Kamocki K; Doyle T; Snider A; Esposito E; Cuzzocrea S; Bieberich E; Obeid L; Petrache I; Nicol G; Neumann WL; Salvemini D
    J Biol Chem; 2014 Jul; 289(30):21082-97. PubMed ID: 24876379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
    Doolen S; Iannitti T; Donahue RR; Shaw BC; Grachen CM; Taylor BK
    Pain; 2018 Feb; 159(2):224-238. PubMed ID: 29140922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Sphingosine-1-Phosphate Receptor 1 in the Spinal Cord Produces Mechanohypersensitivity Through the Activation of Inflammasome and IL-1β Pathway.
    Doyle TM; Chen Z; Durante M; Salvemini D
    J Pain; 2019 Aug; 20(8):956-964. PubMed ID: 30802544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
    Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
    Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
    Li C; Li JN; Kays J; Guerrero M; Nicol GD
    J Neuroinflammation; 2015 Apr; 12():70. PubMed ID: 25880547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine 1-phosphate receptor modulation attenuate mechanical allodynia in mouse model of chronic complex regional pain syndrome by suppressing pathogenic astrocyte activation.
    Lee BJ; Kim JY; Cho HJ; Park D
    Reg Anesth Pain Med; 2020 Mar; 45(3):230-238. PubMed ID: 31969447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.
    Stone ML; Sharma AK; Zhao Y; Charles EJ; Huerter ME; Johnston WF; Kron IL; Lynch KR; Laubach VE
    Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(12):L1245-52. PubMed ID: 25910934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.
    Grenald SA; Doyle TM; Zhang H; Slosky LM; Chen Z; Largent-Milnes TM; Spiegel S; Vanderah TW; Salvemini D
    Pain; 2017 Sep; 158(9):1733-1742. PubMed ID: 28570482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate receptor 1 agonist SEW2871 alters membrane properties of late-firing somatostatin expressing neurons in the central lateral amygdala.
    Mork BE; Lamerand SR; Zhou S; Taylor BK; Sheets PL
    Neuropharmacology; 2022 Feb; 203():108885. PubMed ID: 34798130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
    Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
    J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors.
    Zhang DD; Linke B; Suo J; Zivkovic A; Schreiber Y; Ferreirós N; Henke M; Geisslinger G; Stark H; Scholich K
    Biol Chem; 2015 Jun; 396(6-7):783-94. PubMed ID: 25720064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents.
    Doyle TM; Hutchinson MR; Braden K; Janes K; Staikopoulos V; Chen Z; Neumann WL; Spiegel S; Salvemini D
    J Neuroinflammation; 2020 Oct; 17(1):314. PubMed ID: 33092620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers.
    Cartwright TA; Campos CR; Cannon RE; Miller DS
    J Cereb Blood Flow Metab; 2013 Mar; 33(3):381-8. PubMed ID: 23168528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
    Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.
    Nagahashi M; Yamada A; Katsuta E; Aoyagi T; Huang WC; Terracina KP; Hait NC; Allegood JC; Tsuchida J; Yuza K; Nakajima M; Abe M; Sakimura K; Milstien S; Wakai T; Spiegel S; Takabe K
    Cancer Res; 2018 Apr; 78(7):1713-1725. PubMed ID: 29351902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury.
    Bajwa A; Rosin DL; Chroscicki P; Lee S; Dondeti K; Ye H; Kinsey GR; Stevens BK; Jobin K; Kenwood BM; Hoehn KL; Lynch KR; Okusa MD
    J Am Soc Nephrol; 2015 Apr; 26(4):908-25. PubMed ID: 25145931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure.
    Cantalupo A; Gargiulo A; Dautaj E; Liu C; Zhang Y; Hla T; Di Lorenzo A
    Hypertension; 2017 Aug; 70(2):426-434. PubMed ID: 28607130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
    Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
    Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.